Novartis may divest generic unit Sandoz as price pressures mount

Go back to Novartis may divest generic unit Sandoz as price pressures mount

Novartis's (NVS) Sandoz Said Valued at Over $20 Billion as Standalone Unit - Bloomberg

October 26, 2021 12:26 PM EDT

Novartis's (NYSE: NVS) Sandoz Said Valued at Over $20 Billion as Standalone Unit - Bloomberg

Said to Pick BofA and UBS for Sale, Spinoff
... More